ATEC
Price
$10.99
Change
+$0.03 (+0.27%)
Updated
Jul 3 closing price
Capitalization
1.9B
27 days until earnings call
MYGN
Price
$5.60
Change
-$0.03 (-0.53%)
Updated
Jul 3 closing price
Capitalization
1.93B
27 days until earnings call
Interact to see
Advertisement

ATEC vs MYGN

Header iconATEC vs MYGN Comparison
Open Charts ATEC vs MYGNBanner chart's image
Alphatec Holdings
Price$10.99
Change+$0.03 (+0.27%)
Volume$777.4K
Capitalization1.9B
Myriad Genetics
Price$5.60
Change-$0.03 (-0.53%)
Volume$463.76K
Capitalization1.93B
ATEC vs MYGN Comparison Chart in %
Loading...
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATEC vs. MYGN commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEC is a StrongBuy and MYGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ATEC: $10.99 vs. MYGN: $5.60)
Brand notoriety: ATEC and MYGN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATEC: 45% vs. MYGN: 19%
Market capitalization -- ATEC: $1.9B vs. MYGN: $1.93B
ATEC [@Medical Specialties] is valued at $1.9B. MYGN’s [@Medical Specialties] market capitalization is $1.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATEC’s FA Score shows that 0 FA rating(s) are green whileMYGN’s FA Score has 1 green FA rating(s).

  • ATEC’s FA Score: 0 green, 5 red.
  • MYGN’s FA Score: 1 green, 4 red.
According to our system of comparison, MYGN is a better buy in the long-term than ATEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATEC’s TA Score shows that 5 TA indicator(s) are bullish while MYGN’s TA Score has 5 bullish TA indicator(s).

  • ATEC’s TA Score: 5 bullish, 4 bearish.
  • MYGN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MYGN is a better buy in the short-term than ATEC.

Price Growth

ATEC (@Medical Specialties) experienced а +0.83% price change this week, while MYGN (@Medical Specialties) price change was +5.07% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

ATEC is expected to report earnings on Jul 31, 2025.

MYGN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MYGN($1.93B) and ATEC($1.9B) have the same market capitalization . ATEC YTD gains are higher at: 19.717 vs. MYGN (-59.154). ATEC has higher annual earnings (EBITDA): -110.59M vs. MYGN (-197.4M). ATEC has more cash in the bank: 221M vs. MYGN (141M). MYGN has less debt than ATEC: MYGN (152M) vs ATEC (542M). MYGN has higher revenues than ATEC: MYGN (753M) vs ATEC (482M).
ATECMYGNATEC / MYGN
Capitalization1.9B1.93B99%
EBITDA-110.59M-197.4M56%
Gain YTD19.717-59.154-33%
P/E RatioN/AN/A-
Revenue482M753M64%
Total Cash221M141M157%
Total Debt542M152M357%
FUNDAMENTALS RATINGS
ATEC vs MYGN: Fundamental Ratings
ATEC
MYGN
OUTLOOK RATING
1..100
6116
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
5665
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MYGN's Valuation (97) in the Biotechnology industry is in the same range as ATEC (99) in the Medical Specialties industry. This means that MYGN’s stock grew similarly to ATEC’s over the last 12 months.

ATEC's Profit vs Risk Rating (67) in the Medical Specialties industry is somewhat better than the same rating for MYGN (100) in the Biotechnology industry. This means that ATEC’s stock grew somewhat faster than MYGN’s over the last 12 months.

MYGN's SMR Rating (93) in the Biotechnology industry is in the same range as ATEC (100) in the Medical Specialties industry. This means that MYGN’s stock grew similarly to ATEC’s over the last 12 months.

ATEC's Price Growth Rating (56) in the Medical Specialties industry is in the same range as MYGN (65) in the Biotechnology industry. This means that ATEC’s stock grew similarly to MYGN’s over the last 12 months.

MYGN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for ATEC (100) in the Medical Specialties industry. This means that MYGN’s stock grew significantly faster than ATEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATECMYGN
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 12 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAILX12.21N/A
N/A
Brown Advisory Sustainable Intl Ldrs Ins
HGICX48.81N/A
N/A
Hartford Core Equity C
HWACX35.71N/A
N/A
Hotchkis & Wiley Value Opps C
NSCFX51.99N/A
N/A
Nuveen Small-Cap Value Opps R6
SWMCX70.50N/A
N/A
Schwab ® US Mid-Cap Index

MYGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYGN has been loosely correlated with WAT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MYGN jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYGN
1D Price
Change %
MYGN100%
-0.53%
WAT - MYGN
39%
Loosely correlated
-0.48%
ATEC - MYGN
34%
Loosely correlated
+0.27%
VCYT - MYGN
31%
Poorly correlated
-0.25%
AORT - MYGN
31%
Poorly correlated
-0.42%
GH - MYGN
29%
Poorly correlated
+0.64%
More